...
机译:BCL-2家族蛋白在T / N细胞系ALK阳性和ALK阴性间变性大细胞淋巴瘤中的差异表达
From the Departments of Lymphoma-Myeloma,University of Texas M.D. Anderson Cancer Center, Houston, Texas|and Hematopathology,University of Texas M.D. Anderson Cancer Center, Houston, Texas;
From the Departments of Lymphoma-Myeloma,University of Texas M.D. Anderson Cancer Center, Houston, Texas;
From the Departments of Lymphoma-Myeloma,University of Texas M.D. Anderson Cancer Center, Houston, Texas;
and Hematopathology,University of Texas M.D. Anderson Cancer Center, Houston, Texas;
From the Departments of Lymphoma-Myeloma,University of Texas M.D. Anderson Cancer Center, Houston, Texas;
Molecular Pathology,University of Texas M.D. Anderson Cancer Center, Houston, Texas;
and Hematopathology,University of Texas M.D. Anderson Cancer Center, Houston, Texas;
机译:Bcl-2家族蛋白的差异表达确定人滤泡性淋巴瘤细胞对地塞米松介导和抗BCR介导的细胞凋亡的敏感性。
机译:克唑替尼(PF-2341066)诱导NPM-ALK +间变性大细胞淋巴瘤中pSTAT3和BCL-2家族蛋白的下调导致细胞凋亡
机译:B细胞淋巴瘤-2(BCL-2)同源结构域3(BH3)模拟物证明了依赖于副和抗凋亡Bcl-2家族蛋白的功能性曲目的差异活性
机译:用于研究ALK〜(+)促进大细胞淋巴瘤的异常信号通路的NPM-ALK鉴定的差异表达血浆膜蛋白的表征
机译:了解JunB转录因子在间变性淋巴瘤激酶阳性,间变性大细胞淋巴瘤中的功能。
机译:BCL-2家族蛋白在T / N细胞系ALK阳性和ALK阴性间变性大细胞淋巴瘤中的差异表达
机译:BCL-2家族蛋白在T / N细胞系ALK阳性和ALK阴性间变性大细胞淋巴瘤中的差异表达